Martti Kulvik - Concepedia

Author

Martti Kulvik

Helsinki University Hospital

Also Known As

Kulvik M, Kulvik, Martti, M Kulvik, M. Kulvik, M.E Kulvik, MARTTI KULVIK, Martti Kulvik

Publications

563

Citations

H-Index

Concepts

All Affiliations

Helsinki University Hospital University of Helsinki VTT Technical Research Centre of Finland Research Institute of the Finnish Economy Finnish Safety and Chemicals Agency

About

Martti Kulvik is an author at Helsinki University Hospital specializing in radiation oncology, medicine, and nuclear medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	292
2	Business	2	2	37
3	Health Sciences	2	2	247
4	Engineering	1	1	22
5	Law	1	1	15

Martti Kulvik

Publications

441

Citations

H-Index

Page 1

	Year	Citations
Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine Heikki Joensuu, Leena Kankaanranta, Tiina Seppälä, Journal of Neuro-Oncology Neuro-oncologyGliomaRadiation TherapyClinical TrialsBrain Tumors	2003	210
Atomic Emission Method for Total Boron in Blood during Neutron-Capture Therapy Juha Laakso, Martti Kulvik, Inkeri Ruókonen, Clinical Chemistry	2001	64
Biokinetic analysis of tissue boron (10B) concentrations of glioma patients treated with BNCT in Finland Hanna Koivunoro, Eero Hippeläinen, Iiro Auterinen, Applied Radiation and Isotopes MedicineGlioma PatientsBiokinetic AnalysisTissue BoronHigh-grade Gliomas	2015	37
Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET Katja Havu-Aurén, Johanna Kiiski, Kaisa Lehtiö, European Journal of Nuclear Medicine and Molecular Imaging Neuro-oncologyNeurofibromatosis 2-Related SchwannomaPathologyNeuropathologyMedicine	2006	27
International mega-trends and growth prospects of the Finnish biotechnology industry: Recent economic research and policy implications Raine Hermans, Martti Kulvik, Pekka Ylä-Anttila Journal of Commercial Biotechnology EngineeringEconomic DevelopmentEndogenous Growth TheoryEconomic GrowthIndustrial Organization	2005	22
Non-linear model for the kinetics of<sup>10</sup>B in blood after BPA–fructose complex infusion Päivi Ryynänen, Aki Kangasmäki, Pekka Hiismäki, Physics in Medicine and Biology	2002	21
Clinical implementation of 4-dihydroxyborylphenylalanine synthesised by an asymmetric pathway Martti Kulvik, Jyrki Vähätalo, E. Buchar, European Journal of Pharmaceutical Sciences MedicinePharmacotherapyDrug DevelopmentClinical ImplementationPharmacology	2003	18
BIOTECHNOLOGY AS A COMPETITIVE EDGE FOR THE FINNISH FOREST CLUSTER Terhi K. Hakala, Olli Haltia, Raine Hermans, Econstor (Econstor)	2007	17
PATENT CITATIONS INDICATING PRESENT VALUE OF THE BIOTECHNOLOGY BUSINESS Tuomo Nikulainen, Raine Hermans, Martti Kulvik International Journal of Innovation and Technology Management Business IntelligenceLawPatent StatisticsBusiness AnalyticsThe Biotechnology Business	2008	15
Biodistribution of boron after intravenous 4-dihydroxyborylphenylalanine-fructose (BPA-F) infusion in meningioma and schwannoma patients: A feasibility study for boron neutron capture therapy Martti Kulvik, Merja Kallio, Juha Laakso, Applied Radiation and Isotopes PharmacologyRadiation OncologySchwannoma PatientsFeasibility Study	2015	10

Page 1